SEATTLE, August 4, 2025 — The Gates Foundation has announced a historic $2.5 billion commitment through 2030 to accelerate research and development (R&D) focused exclusively on women’s health, a sector the organization says has been “chronically underfunded for far too long.”
The investment will support over 40 innovations across five critical areas that disproportionately affect women—particularly those in low- and middle-income countries:
-
Obstetric care and maternal immunization
-
Maternal health and nutrition
-
Gynecological and menstrual health
-
Contraceptive innovation
-
Sexually transmitted infections (STIs)
“For too long, women have suffered from health conditions that are misunderstood, misdiagnosed, or ignored,” said Dr. Anita Zaidi, president of the foundation’s Gender Equality Division. “We want this investment to spark a new era of women-centered innovation—one where women’s lives, bodies, and voices are prioritized in health R&D.”
Why It Matters: Women’s Health Remains Underfunded
Despite affecting hundreds of millions worldwide, only 1% of healthcare research funding goes toward female-specific conditions beyond oncology, according to a 2021 McKinsey analysis. Conditions like preeclampsia, endometriosis, heavy menstrual bleeding, gestational diabetes, and menopause remain under-researched, leaving women vulnerable to preventable suffering and death.
“Investing in women’s health has a lasting impact across generations. It leads to healthier families, stronger economies, and a more just world,” said Bill Gates, chair of the foundation. “Yet women’s health continues to be ignored, underfunded, and sidelined. Too many women still die from preventable causes or live in poor health. That must change.”
Catalyzing Innovation Where It’s Needed Most
The funding aims to deliver breakthroughs such as:
-
First-in-class therapeutics for preeclampsia
-
Research into the vaginal microbiome
-
Non-hormonal contraception
The foundation is also calling on governments, philanthropists, and private investors to co-invest and help ensure access for women who need these innovations most.
“This is the largest investment we’ve ever made in women’s health R&D, but it still falls far short of what is needed in a neglected and underfunded area of huge human need and opportunity,” Zaidi said. “Women’s health is not just a philanthropic cause—it’s an investable opportunity with immense potential for scientific breakthroughs.”
A Global Call to Action
Experts say this commitment is overdue. Dr. Bosede Afolabi, professor of obstetrics and gynecology at the University of Lagos, noted:
“We see the consequences of underinvestment in women’s health innovation every day when women suffer needlessly, and sometimes lose their lives. This commitment brings much-needed attention to the health challenges women face in places where resources are most limited and the burden is highest.”
The Economic Impact
Research suggests that every $1 invested in women’s health yields $3 in economic growth, and closing the gender health gap could add $1 trillion per year to the global economy by 2040.
The initiative builds on the Gates Foundation’s long-standing work in maternal and child health and supports its broader mission to end preventable deaths of moms and babies, fight infectious diseases, and reduce poverty worldwide.
